1359. Activity of Meropenem/Nacubactam Combination Against Gram-Negative Clinical Isolates: ROSCO Global Surveillance 2017

BACKGROUND: Nacubactam (NAC, OP0595, RG6080) is a novel member of the diazabicyclooctane inhibitor family with a dual mode of action, acting as a β-lactamase inhibitor and an antibacterial agent by means of PBP2 inactivation. NAC restores and extends the activity of β-lactam antibiotics, such as mer...

Descripción completa

Detalles Bibliográficos
Autores principales: Okujava, Rusudan, Garcia-Alcalde, Fernando, Haldimann, Andreas, Zampaloni, Claudia, Morrissey, Ian, Magnet, Sophie, Kothari, Nimmi, Harding, Ian, Bradley, Kenneth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252560/
http://dx.doi.org/10.1093/ofid/ofy210.1190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252560/
http://dx.doi.org/10.1093/ofid/ofy210.1190

Ejemplares similares